Biocon Biologics gets complete response letter from USFDA for Biosimilar Insulin Aspart
The company had submitted a comprehensive Corrective and Preventive Action (CAPA) plan in September 2022
The company had submitted a comprehensive Corrective and Preventive Action (CAPA) plan in September 2022
Biocon will be responsible for obtaining regulatory approval for Liraglutide, and thereafter, for the manufacture and supply of the product in the Canadian market
Sugammadex Injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide
Dr. Singh proposes upskilling medicos with AI, Quantum and other newer technologies to meet the changing requirements of patient care
Tolvaptan Tablets (RLD Jynarque) had estimated annual sales of USD 287 million in the U.S. (IQVIA MAT August 2023)
The World Homoeopathy Day commemorates the birth anniversary of Dr Samuel Hahnemann on 10th of April
This integrated care offering is a step forward in our vision of providing an effective continuum of care for patients
The Main campaign started from October 2
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
Subscribe To Our Newsletter & Stay Updated